![](https://endpts.com/wp-content/uploads/2023/09/Jeff-Baxter-VBI-Vaccines-CEO.jpg)
Jeff Baxter, VBI Vaccines CEO
First shot at pan-coronavirus vaccine disappoints in VBI Vaccines study
The first data from a clinical trial of a vaccine designed to protect against many kinds of coronaviruses suggest that efforts to significantly improve over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.